Search company, investor...

Microsurge

Stage

Acquired | Acquired

Total Raised

$6.7M

Valuation

$0000 

About Microsurge

Improved instrumentation for minimally invasive surgery. Acquired by UroHealth, renamed Imagyn Medical Technologies, Inc.

Headquarters Location

Missing: Microsurge's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Microsurge's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Latest Microsurge News

1997 PR Newswire Association LLC 16 May. Urohealth Systems, Inc. Acquires Microsurge, Inc. - Free Online Library

May 16, 2016

<a href="http://www.thefreelibrary.com/Urohealth+Systems%2c+Inc.+Acquires+Microsurge%2c+Inc.-a019203116</a> Citations: MLA style: "Urohealth Systems, Inc. Acquires Microsurge, Inc.." The Free Library. 2016 http://www.thefreelibrary.com/Urohealth+Systems%2c+Inc.+Acquires+Microsurge%2c+Inc.-a019203116 Chicago style: The Free Library. S.v. Urohealth Systems, Inc. Acquires Microsurge, Inc.." Retrieved May 16 2016 from http://www.thefreelibrary.com/Urohealth+Systems%2c+Inc.+Acquires+Microsurge%2c+Inc.-a019203116 APA style: Urohealth Systems, Inc. Acquires Microsurge, Inc.. (n.d.) >The Free Library. (2014). Retrieved May 16 2016 from http://www.thefreelibrary.com/Urohealth+Systems%2c+Inc.+Acquires+Microsurge%2c+Inc.-a019203116 NEWPORT BEACH, Calif., March 13 /PRNewswire/ -- UROHEALTHSystems, Inc. (Nasdaq: UROH), today announced that it has acquiredMicrosurge, Inc., a privately held medical device company located inNeedham, Massachusetts, in a transaction valued at $38 million. Thetotal consideration was approximately $29 million of UROHEALTH commonstock and the assumption of $9 million of debt. Additional terms of theagreement were not disclosed. Microsurge, Inc. specializes in developing, manufacturing andmarketing innovative, ergonomic instruments for minimally invasivesurgical procedures, including laparoscopy and emerging applicationssuch as thoracoscopy. With continued pressure on the health care systemto reduce costs, Microsurge is designing high performance, multi-useinstruments to be used in lieu of disposables which could significantlylower per procedure instrumentation costs. Microsurge has already commercialized two major multi-use productlines targeted for laparoscopy, which is performed in more than 2.4million surgical cases annually, with the instrumentation costsexceeding $1 billion per year. These lines include DetachaTip scissors,graspers and dissectors, which are used to cut and manipulate tissuesand organs, and DetachaPort trocars, which enable surgeons to access theabdominal cavity. To complete its laparoscopy line, Microsurge hasdeveloped two additional product offerings, DetachaClip multi-use clipappliers and CoolTec multi-use electrocautery devices, which areexpected to be launched later this year. The company is also pioneering the development of multi-useinstrumentation for thoracic procedures, a new and growing area withinthe minimally invasive surgery market. The number of thoracoscopyprocedures is expected to more than double in the next five years fromits current rate of 92,000 cases per year as new applications develop.Currently, Microsurge is collaborating with surgeons at Brigham andWomen's Hospital in Boston, Massachusetts on a product line forLung Volume Reduction procedures, a new surgical technique undergoingclinical evaluation for treatment of emphysema, a disease that afflictsmore than 2 million people in the U.S. E. James Hutchens, Chairman and Chief Executive Officer ofMicrosurge, Inc., noted, "Joining forces with UROHEALTH, a strongand growing presence in the minimally invasive surgery market, is agreat opportunity for Microsurge and its shareholders. UROHEALTH'sproduct strategy is consistent with our own offering complementary MISportfolios of cost-effective, highly differentiated instruments to meetthe changing needs of the health care system. Backed by the significantmarketing and distribution capabilities of UROHEALTH's directsalesforce, Microsurge will have the resources required to more rapidlyincrease the market penetration of existing and future multi-useinstrumentation lines. " Charles A. Laverty, Chairman and Chief Executive Officer ofUROHEALTH Systems, Inc., commented, "Over the past five years,Microsurge has developed products that capitalize on new and growingapplications and techniques for minimally invasive surgery. In ourestimation, the unique, multi-use feature, coupled with the qualitydesign, makes these instrumentation lines the right choice for the MISmarketplace from both an economic and performance standpoint. ForUROHEALTH, the acquisition of Microsurge's technology base, as wellas its products, gives us a strong foundation upon which to build anextensive franchise in multi-use MIS products. " UROHEALTH Systems, Inc. is a designer, manufacturer and marketerof disease specific urological, gynecological and general surgerymedical products for the health care market. This press release contains, in addition to historicalinformation, forward-looking statements, that involve risks anduncertainties. These include statements regarding the Company'sgrowth and expansion plans. Such statements are based uponmanagement's current expectations and are subject to a number ofuncertainties and risks that could cause actual results to differmaterially from those described in the forward looking statements. SOURCE UROHEALTH Systems, Inc. -0- 03/13/97 /CONTACT: Charles A. Laverty, Chairman and Chief ExecutiveOfficer, or James Johnson, Executive Vice President & CFO, ofUROHEALTH, 714-668-5858; or Investor Relations: Betsy Brod or AlexGleeson, or Media: Miriam Adler or Erika Brown, of Morgen-WalkeAssociates, 212-850-5600/ (UROH) CO: UROHEALTH Systems, Inc.; Microsurge, Inc. ST: California IN:MTC SU: TNM GW -- NYTH057 -- 6024 03/13/97 07:45 EST http://www.prnewswire.com COPYRIGHT 1997 PR Newswire Association LLC No portion of this article can be reproduced without the express written permission from the copyright holder. Copyright 1997 Gale, Cengage Learning. All rights reserved. Article Details

Microsurge Frequently Asked Questions (FAQ)

  • What is Microsurge's latest funding round?

    Microsurge's latest funding round is Acquired.

  • How much did Microsurge raise?

    Microsurge raised a total of $6.7M.

  • Who are the investors of Microsurge?

    Investors of Microsurge include Urohealth Sytems and Domain Associates.

  • Who are Microsurge's competitors?

    Competitors of Microsurge include Spineology, VisionSense, FloShield, PEAK Surgical, TransCorp Medical and 11 more.

Compare Microsurge to Competitors

A
Axis Surgical Technologies

Axis Surgical Technologies, Inc. aims to develop, manufacture, and market devices that improve quality and efficiency in spinal surgery, especially for minimally invasive surgical techniques. Based in Mountain View, California, Axis offers an integration of visualization and articulation capabilities and provides spinal surgery equipment. Axis' FDA Grant In March 2010, Axis announced that it received 510(k) clearance from the Food and Drug Administration to market its C-MOR„ Visualization Device to use in diagnostic and operative arthroscopic and endoscopic procedures. This portable tool provides visualization and illumination of an interior cavity through either a natural or surgical opening. The ergonomic lightweight device also offers practitioners the convenience of endoscopic visualization and efficient one-handed operating ability; this device can be employed in hospital outpatient departments, ambulatory surgery centers, and office surgery suites.

A
Alure Medical

Alure Medical offers minimally invasive aesthetic surgery products.

A
Advanced Surgical Concepts

Advanced Surgical Concepts develops surgical instruments for use in endoscopy and in minimally invasive surgery

N
Neurosonix

NeuroSonix is an Israeli medical device company targeting the market of cerebral embolic protection during cardiac surgical and other minimally invasive procedures. NeuroSonix has conceived, developed and patented a technology and medical devices for the prevention of acute cerebral embolism during open-heart cardiac surgery as well as other invasive and minimally-invasive procedures. The company's technology, which is based on ultrasound, aims to enable a non-invasive deflection of embolic material flowing inside the body, away from the cerebral arteries. This new ultrasonic modality aims to reduce the embolic load on the patient's brain. The first product developed by the company is the EmBlocker"ž, intended to provide protection from acute cerebral embolism during cardiac surgical procedures. The Protection Collar, the company's second product, is intended for embolic protection during minimally-invasive procedures and Cath-lab practice.

U
UltraCision

UltraCision develops and manufactures the Harmonic Scalpel, an ultrasound powered medical instrument for minimally invasive surgery.

T
TransCorp Medical

TransCorp Medical is developing products for minimally invasive, motion-preserving spinal surgery. The company was formed in 2008.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.